WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Biosciences Inc Stock Ownership - Who owns Coherus Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Coherus Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mats WahlstromDirector2024-02-0144,991$1.67
$75.00kBuy
Mats WahlstromDirector2024-02-0114,997$1.67
$25.00kBuy
Bryan J. McMichaelOfficer2024-01-201,707$2.44
$4.17kSell
Dennis M. LanfearPresident CEO2024-01-2011,218$2.44
$27.37kSell
Paul ReiderChief Commercial Officer2024-01-204,854$2.44
$11.84kSell
Bryan J. McMichaelOfficer2024-01-071,707$2.87
$4.90kSell
Dennis M. LanfearPresident CEO2024-01-0411,781$2.92
$34.40kSell
Paul ReiderChief Commercial Officer2024-01-042,275$2.92
$6.64kSell
Mcdavid StilwellChief Financial Officer2023-12-3118,440$3.33
$61.41kSell
Paul ReiderChief Commercial Officer2023-12-132,049$2.37
$4.86kSell

1 of 2

CHRS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.71%12,074,695$26.32MInstitution
Vanguard Group Inc9.19%10,357,412$22.58MInstitution
Vsciences Investments Pte Ltd6.55%7,381,116$16.09MInsider
Temasek Holdings Private Ltd6.55%7,381,116$16.09MInstitution
Barclays PLC3.09%3,484,395$7.60MInstitution
Lilly Co Eli2.70%3,042,019$6.63MInsider
Kohlberg Kravis Roberts Co LP2.69%3,036,076$6.62MInstitution
Daiichi Sankyo Company Ltd2.54%2,867,426$6.25MInsider
Millennium Management LLC2.52%2,842,319$6.20MInstitution
Dennis M. Lanfear2.30%2,587,071$5.64MInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS72.75%18.69%Net BuyingNet Buying
PBYI55.20%44.43%Net Selling
VSTM25.42%74.58%Net SellingNet Selling
INO61.56%38.44%Net SellingNet Selling
XBIT11.32%45.18%
View Top Biotech Stocks

Coherus Biosciences Stock Ownership FAQ

Who owns Coherus Biosciences?

Coherus Biosciences (NASDAQ: CHRS) is owned by 72.75% institutional shareholders, 18.69% Coherus Biosciences insiders, and 8.56% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Biosciences shareholder, owning 7.38M shares representing 6.55% of the company. Vsciences Investments Pte Ltd's Coherus Biosciences shares are currently valued at $16.09M.

If you're new to stock investing, here's how to buy Coherus Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.